Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Infect Immun ; 90(2): e0022221, 2022 02 17.
Article in English | MEDLINE | ID: mdl-34978927

ABSTRACT

Hypoxia-inducible transcription factor 1 (HIF-1) has been shown to enhance microbial killing and ameliorate the course of bacterial infections. While the impact of HIF-1 on inflammatory diseases of the gut has been studied intensively, its function in bacterial infections of the gastrointestinal tract remains largely elusive. With the help of a publicly available gene expression data set, we inferred significant activation of HIF-1 after oral infection of mice with Salmonella enterica serovar Typhimurium. Immunohistochemistry and Western blot analyses confirmed marked HIF-1α protein stabilization, especially in the intestinal epithelium. This prompted us to analyze conditional Hif1a-deficient mice to examine cell type-specific functions of HIF-1 in this model. Our results demonstrate enhanced noncanonical induction of HIF-1 activity upon Salmonella infection in the intestinal epithelium as well as in macrophages. Surprisingly, Hif1a deletion in intestinal epithelial cells did not impact inflammatory gene expression, bacterial spread, or disease outcomes. In contrast, Hif1a deletion in myeloid cells enhanced intestinal Cxcl2 expression and reduced the cecal Salmonella load. In vitro, HIF-1α-deficient macrophages showed overall impaired transcription of mRNA encoding proinflammatory factors; however, the intracellular survival of Salmonella was not impacted by HIF-1α deficiency.


Subject(s)
Salmonella Infections , Salmonella typhimurium , Animals , Epithelial Cells/microbiology , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Intestinal Mucosa/microbiology , Macrophages , Mice , Salmonella Infections/genetics , Salmonella typhimurium/genetics
2.
Mol Microbiol ; 101(5): 809-22, 2016 09.
Article in English | MEDLINE | ID: mdl-27196733

ABSTRACT

Many enzymes require the molybdenum cofactor, Moco. Under Mo-limiting conditions, the high-affinity ABC transporter ModABC permits molybdate uptake and Moco biosynthesis in bacteria. Under Mo-replete conditions, Escherichia coli represses modABC transcription by the one-component regulator, ModE, consisting of a DNA-binding and a molybdate-sensing domain. Instead of a full-length ModE protein, many bacteria have a shorter ModE protein, ModE(S) , consisting of a DNA-binding domain only. Here, we asked how such proteins sense the intracellular molybdenum status. We show that the Agrobacterium tumefaciens ModE(S) protein Atu2564 is essential for modABC repression. ModE(S) binds two Mo-boxes in the modA promoter as shown by electrophoretic mobility shift assays. Northern analysis revealed cotranscription of modE(S) with the upstream gene, atu2565, which was dispensable for ModE(S) activity. To identify genes controlling ModE(S) function, we performed transposon mutagenesis. Tn5 insertions resulting in derepressed modA transcription mapped to the atu2565-modE(S) operon and several Moco biosynthesis genes. We conclude that A. tumefaciens ModE(S) activity responds to Moco availability rather than to molybdate concentration directly, as is the case for E. coli ModE. Similar results in Sinorhizobium meliloti suggest that Moco dependence is a common feature of ModE(S) regulators.


Subject(s)
Agrobacterium tumefaciens/metabolism , Coenzymes/metabolism , Metalloproteins/metabolism , Molybdenum/metabolism , Pteridines/metabolism , Agrobacterium tumefaciens/genetics , Amino Acid Sequence , Base Sequence , Coenzymes/biosynthesis , Coenzymes/genetics , Escherichia coli/genetics , Escherichia coli Proteins/metabolism , Inverted Repeat Sequences , Metalloproteins/biosynthesis , Metalloproteins/genetics , Molybdenum Cofactors , Operon , Promoter Regions, Genetic , Transcription Factors/metabolism
3.
Cancer Lett ; 490: 186-192, 2020 10 10.
Article in English | MEDLINE | ID: mdl-32711098

ABSTRACT

Colorectal cancer ranks among the top three most frequent malignancies in the world. While overall incidence and mortality of colorectal cancer has substantially decreased in recent years, tumor subtypes with poor response rates to standard antiproliferative therapies remain particularly challenging. Hypoxia in the microenvironment of solid tumors is associated with malignant progression, e.g. local invasion, systemic spread and therapy resistance. A detailed molecular understanding of hypoxia's role for the pathobiology of colorectal cancer is a prerequisite to design and evaluate the consequences of interference with hypoxic signaling for the progression of this cancer type. Here, we summarize the current knowledge about the role of hypoxia-inducible factor 1, an essential molecular mediator of the hypoxic response, for colorectal cancer pathogenesis. Special attention is given to intestinal microbiota, gut barrier integrity and chronic inflammation as these are of pivotal importance for intestinal tumorigenesis and noticeably associated with hypoxic signaling.


Subject(s)
Carcinogenesis/metabolism , Colorectal Neoplasms/pathology , Hypoxia-Inducible Factor 1/metabolism , Inflammation/pathology , Intestinal Mucosa/pathology , Animals , Cell Hypoxia/physiology , Colorectal Neoplasms/metabolism , Gastrointestinal Microbiome/physiology , Humans , Inflammation/metabolism , Intestinal Mucosa/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL